Patents by Inventor Philip J. Shea

Philip J. Shea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glaucine analgesic method
    Patent number: 4183939
    Abstract: A method of alleviating pain in animals comprising administering l-glaucine, d,l-glaucine their pharmaceutically-acceptable salts or mixtures thereof. The levorotary and racemic glaucine compounds have analgesic activity, both orally and parenterally, with a low incidence of side effects.
    Type: Grant
    Filed: September 1, 1978
    Date of Patent: January 15, 1980
    Assignee: The Dow Chemical Company
    Inventors: Thomas H. Gieske, Philip J. Shea
  • Method for treating depression and anxiety using phenyl hydrazo compounds
    Patent number: 4150133
    Abstract: Methods and pharmaceutical compositions using substituted phenyl hydrazo compounds for the treatment of depression and/or anxiety in a mammal.
    Type: Grant
    Filed: April 18, 1978
    Date of Patent: April 17, 1979
    Assignee: The Dow Chemical Company
    Inventors: Abdulmuniem H. Abdallah, Philip J. Shea
  • Triazolopyridazines used to alleviate bronchial spasms
    Patent number: 4136182
    Abstract: This invention relates to a method useful for combatting bronchial spasm in mammals by means of administering to mammals a 3,6,8-substituted triazolopyridazine compound such as 8-methyl-6-morpholino-s-triazolo-[4,3-b]pyridazine, 3,8-dimethyl-6-piperidino-s-triazolo-[4,3-b]pyridazine or a pharmacologically-acceptable salt thereof.
    Type: Grant
    Filed: February 13, 1978
    Date of Patent: January 23, 1979
    Assignee: The Dow Chemical Company
    Inventors: Jon Lewis, Philip J. Shea
  • Naphthalene acetamidines as anxiolytic antidepressants
    Patent number: 4134992
    Abstract: A method useful for alleviating central nervous system depression and anxiety symptoms comprises administration to animals of an effective amount of an N,N'-dialkyl-2-naphthalene acetamidine. Compositions useful in practicing the method are also disclosed.
    Type: Grant
    Filed: August 4, 1977
    Date of Patent: January 16, 1979
    Assignee: The Dow Chemical Company
    Inventors: Abdulmuniem H. Abdallah, Philip J. Shea
  • Method for treating depression and anxiety using phenyl hydrazo compounds
    Patent number: 4117146
    Abstract: Methods and pharmaceutical compositions using substituted phenyl hydrazo compounds for the treatment of depression and/or anxiety in a mammal.
    Type: Grant
    Filed: June 27, 1977
    Date of Patent: September 26, 1978
    Assignee: The Dow Chemical Company
    Inventors: Abdulmuniem H. Abdallah, Philip J. Shea
  • Antidepressant phenylazoimidazoles
    Patent number: 4079130
    Abstract: A method for treating Central Nervous System depression and anxiety in a mammal by administering internally to the mammal an effective psychoactive amount of a phenylazoimidazole compound.
    Type: Grant
    Filed: May 6, 1977
    Date of Patent: March 14, 1978
    Assignee: The Dow Chemical Company
    Inventors: Abdulmuniem H. Abdallah, Philip J. Shea
  • Acetamidine urinary antiseptics
    Patent number: 3991210
    Abstract: The disclosure relates to a method useful for combating microorganisms associated with infections of the urinary tract in mammals by means of administering to mammals an amount of a substituted acetamidine compound such as 2-(4-bromophenyl) acetamidine or a pharmacologically-acceptable salt thereof sufficient to provide an antiseptic amount of said compound in the urinary tract or in the urine and compositions useful in practicing the method.
    Type: Grant
    Filed: May 5, 1975
    Date of Patent: November 9, 1976
    Assignee: The Dow Chemical Company
    Inventor: Philip J. Shea
  • N,N'-dialkyl-halobenzamidines as antidepressants
    Patent number: 3988474
    Abstract: A method useful for alleviating central nervous system depression comprises administration to animals of an effective amount of an N,N'-dialkyl-halobenzamidine. Compositions useful in practicing the method are also disclosed.
    Type: Grant
    Filed: September 23, 1975
    Date of Patent: October 26, 1976
    Assignee: The Dow Chemical Company
    Inventors: Abdulmuniem H. Abdallah, Philip J. Shea
  • Halophenyl acetamidines as anxiolytic antidepressants
    Patent number: 3983250
    Abstract: A method useful for alleviating central nervous system depression and anxiety symptoms comprises administration to animals of an effective amount of an N,N'-dialkyl-2-halophenyl acetamidine. Compositions useful in practicing the method are also disclosed.
    Type: Grant
    Filed: October 9, 1975
    Date of Patent: September 28, 1976
    Assignee: The Dow Chemical Company
    Inventors: Abdulmuniem H. Abdallah, Philip J. Shea
  • Anti-inflammatory methods utilizing certain thioureas
    Patent number: 3950538
    Abstract: A method of alleviating symptoms of inflammation in a mammal suffering from an inflammatory condition which comprises the administration to such mammal of a pharmaceutically effective amount of a 1-aryl-3-(2-hydroxyethyl)thiourea derivative.
    Type: Grant
    Filed: November 7, 1974
    Date of Patent: April 13, 1976
    Assignee: The Dow Chemical Company
    Inventor: Philip J. Shea
  • Halophenyl acetamidines as anxiolytic antidepressants
    Patent number: 3934020
    Abstract: A method useful for alleviating central nervous system depression and anxiety symptoms comprises administration to animals of an effective amount of an N,N'-dialkyl-2-halophenyl acetamidine. Compositions useful in practicing the method are also disclosed.
    Type: Grant
    Filed: October 2, 1974
    Date of Patent: January 20, 1976
    Assignee: The Dow Chemical Company
    Inventors: Abdulmuniem H. Abdallah, Philip J. Shea